Mariacarla Andreozzi

1.3k total citations · 1 hit paper
19 papers, 804 citations indexed

About

Mariacarla Andreozzi is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mariacarla Andreozzi has authored 19 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Mariacarla Andreozzi's work include Genetic factors in colorectal cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic function and diabetes (4 papers). Mariacarla Andreozzi is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic function and diabetes (4 papers). Mariacarla Andreozzi collaborates with scholars based in Italy, Switzerland and United States. Mariacarla Andreozzi's co-authors include Luigi Terracciano, Luigi Tornillo, Vienna Ludovini, Lorenza Landi, Elisa Rossi, Federico Cappuzzo, Roberto Incensati, Marco Filice, Spartaco Sani and Gabriele Minuti and has published in prestigious journals such as PLoS ONE, Cancer Research and Diabetes.

In The Last Decade

Mariacarla Andreozzi

19 papers receiving 796 citations

Hit Papers

PD-1 and PD-L1 expression in molecularly selected non-sma... 2014 2026 2018 2022 2014 100 200 300 400

Peers

Mariacarla Andreozzi
SL Moulder United States
Theresa S. Pritchard United States
Sarita Agte United States
Daniel Carvajal United States
SL Moulder United States
Mariacarla Andreozzi
Citations per year, relative to Mariacarla Andreozzi Mariacarla Andreozzi (= 1×) peers SL Moulder

Countries citing papers authored by Mariacarla Andreozzi

Since Specialization
Citations

This map shows the geographic impact of Mariacarla Andreozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariacarla Andreozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariacarla Andreozzi more than expected).

Fields of papers citing papers by Mariacarla Andreozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariacarla Andreozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariacarla Andreozzi. The network helps show where Mariacarla Andreozzi may publish in the future.

Co-authorship network of co-authors of Mariacarla Andreozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mariacarla Andreozzi. A scholar is included among the top collaborators of Mariacarla Andreozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariacarla Andreozzi. Mariacarla Andreozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Phung, Tanya N., Timothy H. Webster, Elizabeth Lenkiewicz, et al.. (2021). Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity. Scientific Reports. 11(1). 10571–10571. 2 indexed citations
2.
Chen, Meixuan, Barbara A. Pockaj, Mariacarla Andreozzi, et al.. (2018). JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer. Clinical Breast Cancer. 18(5). e1205–e1215. 52 indexed citations
3.
4.
Quagliata, Luca, Mariacarla Andreozzi, Serenella Eppenberger‐Castori, et al.. (2017). Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes. PLoS ONE. 12(4). e0175563–e0175563. 15 indexed citations
5.
Andreozzi, Mariacarla, Cristina Quintavalle, D. Benz, et al.. (2016). HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models. Neoplasia. 18(12). 724–731. 36 indexed citations
6.
Cimmino, Flora, Marianna Avitabile, Giulia Scalia, et al.. (2016). CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma. Oncogenesis. 5(4). e212–e212. 10 indexed citations
7.
Andreozzi, Mariacarla, et al.. (2016). Abstract P5-04-19: JAK2 copy number and targeted JAK2 inhibition of TNBC cell lines. Cancer Research. 76(4_Supplement). P5–4. 1 indexed citations
8.
Barrett, Michael T., Karen S. Anderson, Elizabeth Lenkiewicz, et al.. (2015). Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer. Oncotarget. 6(28). 26483–26493. 104 indexed citations
9.
D’Incecco, Armida, Mariacarla Andreozzi, Vienna Ludovini, et al.. (2014). PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients. British Journal of Cancer. 112(1). 95–102. 492 indexed citations breakdown →
10.
Andreozzi, Mariacarla, Luca Quagliata, Joël Gsponer, et al.. (2013). VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities. Angiogenesis. 17(3). 519–527. 18 indexed citations
11.
Quagliata, Luca, Mariacarla Andreozzi, Michal Kováč, et al.. (2013). SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules. European Journal of Cancer. 50(4). 731–738. 8 indexed citations
12.
Ruiz, Christian, Martin Oeggerli, Markus Germann, et al.. (2012). High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. The Prostate. 72(15). 1678–1687. 21 indexed citations
13.
Marchetti, Piero, Gaetano Villani, Mariacarla Andreozzi, et al.. (1994). COLLAGENASE DISTENSION, TWO-STEP SEQUENTIAL FILTRATION, AND HISTOPAQUE GRADIENT PURIFICATION FOR CONSISTENT ISOLATION OF PURE PANCREATIC ISLETS FROM THE MARKET-AGE (6-MONTH-OLD) PIG. Transplantation. 57(10). 1532–1534. 15 indexed citations
14.
Villani, Gaetano, Piero Marchetti, R Giannarelli, et al.. (1994). Comparison of different digestion techniques and density gradient purification procedures to prepare viable pancreatic islets from market age pigs.. PubMed. 26(2). 621–2. 3 indexed citations
15.
Viacava, Paolo, R Giannarelli, Piero Marchetti, et al.. (1994). Morphologic characterization of isolated porcine and bovine islets of Langerhans.. PubMed. 26(3). 1130–1. 1 indexed citations
16.
Giannarelli, R, Piero Marchetti, Nunzia Bernardini, et al.. (1994). Isolation of islets of Langerhans from the chicken pancreas.. PubMed. 26(3). 1127–1127. 2 indexed citations
17.
Giannarelli, R, Piero Marchetti, Gaetano Villani, et al.. (1994). Preparation of pure, viable porcine and bovine islets by a simple method.. PubMed. 26(2). 630–1. 3 indexed citations
18.
Villani, Gaetano, Piero Marchetti, Laura Giusti, et al.. (1994). Optimization of the use of collagenase in porcine islet isolation.. PubMed. 26(3). 1125–6. 1 indexed citations
19.
Giannarelli, R, Pellegrino Masiello, Gaetano Villani, et al.. (1993). COMPARATIVE-STUDY OF INSULIN-SECRETION FROM ISOLATED RAT, PORCINE AND BOVINE ISLETS. Diabetes. 42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026